vs
IRIDEX CORP(IRIX)与REDWOOD TRUST INC(RWT)财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是IRIDEX CORP的1.8倍($25.9M vs $14.7M),REDWOOD TRUST INC同比增速更快(-6.1% vs -69.7%),过去两年IRIDEX CORP的营收复合增速更高(11.9% vs -41.0%)
IRIDEX Corporation是一家全球性医疗科技企业,主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备,产品供应至北美、欧洲、亚太等地区的医疗机构与诊所,为眼部疾病治疗和医美项目提供微创解决方案。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司,主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理,核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务,客户以机构投资者和房地产市场参与者为主。
IRIX vs RWT — 直观对比
营收规模更大
RWT
是对方的1.8倍
$14.7M
营收增速更快
RWT
高出63.7%
-69.7%
两年增速更快
IRIX
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $14.7M | $25.9M |
| 净利润 | — | $20.0M |
| 毛利率 | 37.2% | — |
| 营业利润率 | — | — |
| 净利率 | — | 77.2% |
| 营收同比 | -69.7% | -6.1% |
| 净利润同比 | — | 402.6% |
| 每股收益(稀释后) | — | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IRIX
RWT
| Q4 25 | $14.7M | $25.9M | ||
| Q3 25 | $12.5M | $15.0M | ||
| Q2 25 | $13.6M | $13.8M | ||
| Q1 25 | $11.9M | $27.9M | ||
| Q4 24 | $12.7M | $27.6M | ||
| Q3 24 | $11.6M | $25.5M | ||
| Q2 24 | $12.6M | $67.4M | ||
| Q1 24 | $11.8M | $74.5M |
净利润
IRIX
RWT
| Q4 25 | — | $20.0M | ||
| Q3 25 | $-1.6M | $-7.7M | ||
| Q2 25 | $-994.0K | $-98.5M | ||
| Q1 25 | $-1.7M | $16.1M | ||
| Q4 24 | $-834.0K | $-6.6M | ||
| Q3 24 | $-1.9M | $14.8M | ||
| Q2 24 | $-2.7M | $15.5M | ||
| Q1 24 | $-3.5M | $30.3M |
毛利率
IRIX
RWT
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
营业利润率
IRIX
RWT
| Q4 25 | — | — | ||
| Q3 25 | -11.3% | -9.0% | ||
| Q2 25 | -6.9% | -679.0% | ||
| Q1 25 | -1.7% | 80.2% | ||
| Q4 24 | -3.9% | -1.3% | ||
| Q3 24 | -16.1% | 86.1% | ||
| Q2 24 | -20.9% | 30.3% | ||
| Q1 24 | -28.0% | 41.3% |
净利率
IRIX
RWT
| Q4 25 | — | 77.2% | ||
| Q3 25 | -12.6% | -51.4% | ||
| Q2 25 | -7.3% | -712.0% | ||
| Q1 25 | -14.2% | 57.8% | ||
| Q4 24 | -6.6% | -24.0% | ||
| Q3 24 | -16.7% | 58.1% | ||
| Q2 24 | -21.2% | 23.0% | ||
| Q1 24 | -29.5% | 40.6% |
每股收益(稀释后)
IRIX
RWT
| Q4 25 | — | $0.11 | ||
| Q3 25 | $-0.09 | $-0.08 | ||
| Q2 25 | $-0.06 | $-0.76 | ||
| Q1 25 | $-0.10 | $0.10 | ||
| Q4 24 | $-0.05 | $-0.08 | ||
| Q3 24 | $-0.12 | $0.09 | ||
| Q2 24 | $-0.16 | $0.10 | ||
| Q1 24 | $-0.21 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $255.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $982.6M |
| 总资产 | $29.2M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IRIX
RWT
| Q4 25 | $6.0M | $255.7M | ||
| Q3 25 | $5.6M | $226.3M | ||
| Q2 25 | $6.8M | $302.0M | ||
| Q1 25 | $7.2M | $259.9M | ||
| Q4 24 | $2.4M | $245.2M | ||
| Q3 24 | $3.9M | $253.7M | ||
| Q2 24 | $4.1M | $275.6M | ||
| Q1 24 | $5.4M | $275.4M |
总债务
IRIX
RWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.7B |
股东权益
IRIX
RWT
| Q4 25 | — | $982.6M | ||
| Q3 25 | $4.7M | $999.0M | ||
| Q2 25 | $6.1M | $1.1B | ||
| Q1 25 | $852.0K | $1.2B | ||
| Q4 24 | $2.1M | $1.2B | ||
| Q3 24 | $2.6M | $1.2B | ||
| Q2 24 | $4.2M | $1.2B | ||
| Q1 24 | $6.5M | $1.2B |
总资产
IRIX
RWT
| Q4 25 | $29.2M | $23.7B | ||
| Q3 25 | $28.4M | $22.6B | ||
| Q2 25 | $31.6M | $21.3B | ||
| Q1 25 | $34.2M | $19.9B | ||
| Q4 24 | $29.1M | $18.3B | ||
| Q3 24 | $30.2M | $18.4B | ||
| Q2 24 | $31.2M | $16.5B | ||
| Q1 24 | $34.1M | $15.1B |
负债/权益比
IRIX
RWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
IRIX
RWT
| Q4 25 | — | $-10.1B | ||
| Q3 25 | $-1.2M | $-2.7B | ||
| Q2 25 | $-397.0K | $-2.1B | ||
| Q1 25 | $-1.1M | $-2.0B | ||
| Q4 24 | $-1.2M | $-5.9B | ||
| Q3 24 | $-3.1M | $-2.1B | ||
| Q2 24 | $-1.3M | $-2.0B | ||
| Q1 24 | $-1.6M | $-954.2M |
自由现金流
IRIX
RWT
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-410.0K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.7M | — |
自由现金流率
IRIX
RWT
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14.0% | — |
资本支出强度
IRIX
RWT
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
IRIX
RWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图